Baruch Wolach

Baruch Wolach

Auto-generated profile, based on publicly available information

Baruch Wolach

Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2016 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
BWBaruch Wolach
Baruch Wolach
RGRonit Gavrieli
Ronit Gavrieli
MBMartin de Boer
Martin de Boer
KLKarin van Leeuwen
Karin van Leeuwen
SBSivan Berger‐Achituv
Sivan Berger‐Achituv
DRDirk Roos
Dirk Roos

1 October 2008 in Clinical Immunology
Verified
Journal Article
Closed access
BWBaruch Wolach
Baruch Wolach
RGRonit Gavrieli
Ronit Gavrieli
MBMartin de Boer
Martin de Boer
GGGiora Gottesman
Giora Gottesman
JBJosef Ben-Ari
Josef Ben-Ari
DRDirk Roos
Dirk Roos

1 January 2005 in Blood
Verified
Journal Article
Closed access
PDF file
BWBaruch Wolach
Baruch Wolach
YSYitshak Scharf
Yitshak Scharf
RGRonit Gavrieli
Ronit Gavrieli
MBMartin de Boer
Martin de Boer
DRDirk Roos
Dirk Roos
Most patients with chronic granulomatous disease (CGD) have mutations in the X-linked CYBB gene that encodes gp91phox, a component of the phagocyte NADPH oxidase. The resulting X-linked form of CGD is usually manifested in boys. Rarely, X-CGD is encountered in female carriers with extreme expression of the mutated gene. Here, we report on a woman with a novel mutation in CYBB (CCG[90-92] → GGT), predicting Tyr30Arg31 → stop, Val in gp91phox, who presented with clinical symptoms at the age of 66. The mutation was present in heterozygous form in genomic DNA from her leukocytes but was fully expressed in mRNA from these cells, indicating that in her leukocytes the X chromosome carrying the nonmutated CYBB allele had been inactivated. Indeed, only 0.4% to 2% of her neutrophils showed NADPH oxidase activity. This extreme skewing of her X-chromosome inactivation was not found in her cheek mucosal cells and is thus not due to a general defect in gene methylation on one X chromosome. Moreover, the CYBB mutation was not present in the DNA from her cheek cells and was barely detectable in the DNA from her memory T lymphocytes. Thus, this patient shows a somatic mosaic for the CYBB mutation, which probably originated during her lifetime in her bone marrow.

9 November 2018 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
BWBaruch Wolach
Baruch Wolach
RGRonit Gavrieli
Ronit Gavrieli
OWOfir Wolach
Ofir Wolach
TSTal Stauber
Tal Stauber
OAOmar Abuzaitoun
Omar Abuzaitoun
AEAmos Etzioni
Amos Etzioni

24 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ALAtar Lev
Atar Lev
YLYu Nee Lee
Yu Nee Lee
GSGuangping Sun
Guangping Sun
EHEnas Hallumi
Enas Hallumi
ASAmos J. Simon
Amos J. Simon
RSRaz Somech
Raz Somech
The T cell receptor (TCR) signaling pathway is an ensemble of numerous proteins that are crucial for an adequate immune response. Disruption of any protein involved in this pathway leads to severe immunodeficiency and unfavorable clinical outcomes. Here, we describe an infant with severe immunodeficiency who was found to have novel biallelic mutations in SLP76. SLP76 is a key protein involved in TCR signaling and in other hematopoietic pathways. Previous studies of this protein were performed using Jurkat-derived human leukemic T cell lines and SLP76-deficient mice. Our current study links this gene, for the first time, to a human immunodeficiency characterized by early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation. Hereby, we characterized aspects of the patient's immune phenotype, modeled them with an SLP76-deficient Jurkat-derived T cell line, and rescued some consequences using ectopic expression of wild-type SLP76. Understanding human diseases due to SLP76 deficiency is helpful in explaining the mixed T cell and neutrophil defects, providing a guide for exploring human SLP76 biology.

30 December 2011 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
BWBaruch Wolach
Baruch Wolach
RGRonit Gavrieli
Ronit Gavrieli
DRDirk Roos
Dirk Roos
SBSivan Berger-Achituv
Sivan Berger-Achituv